SLC2A1 and Alzheimer disease: A recent study also demonstrated a significant downregulation of GLUT1 in brain-derived circulating endothelial cells from patients with mild AD [229], suggesting that this process may precede many of the clinical and pathological manifestations of the disease, much like the metabolic dysfunction observed in pre-symptomatic individuals who go on to develop AD.